IMMPORT THERAPEUTICS INC
Doing business as ANTIGEN DISCOVERY INC
- IRVINE, CA 92618-2343
- antigendiscovery.com (company website, opens in a new tab)
- Corporate Entity (Not Tax Exempt)
- SAM active
- No verified credentials yet
- CMMCNot on file
- SPRSNone
- FCLVisible to paid members
- Small Business
Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works
- 36-mo obligations
- $0
- Awards on record
- 0
- Contract vehicles
- 0
- Verified credentials
- 0
Compliance posture: unverified (SAM.gov baseline only)
IMMPORT THERAPEUTICS INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0
About IMMPORT THERAPEUTICS INC
- Headquarters
- IRVINE, CA 92618-2343
Identifiers
UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.
- UEIZJAMPJY7M149
- CAGE4C5L7
Capabilities & differentiators
No capability narrative yet
Compliance posture
No compliance posture published yet
Facility clearance
Facility clearance: visible to paid members
Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans
Past performance
No federal prime awards on record
Contract vehicles
No contract vehicles on file
Proven teaming graph
No sub-award reports yet
Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.
SBIR/STTR portfolio
SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects
Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.
- Awards on record
- 25 awards
- Total awarded
- $16,715,675
- By phase
- SBIR Phase I: 21
- SBIR Phase II: 2
- STTR Phase I: 1
- STTR Phase II: 1
- By agency
- Department of Health and Human Services: 25
- Active projects
- 2 projects
- Projects whose contract end date is today or later.
- Phase II ending within 12 months
- 0 projects
- Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
- By year
- 2025: 2
- 2024: 1
- 2021: 2
- 2020: 2
- 2018: 4
- 2017: 1
- 2016: 1
- 2015: 1
- 2014: 1
- 2012: 2
- 2009: 1
- 2008: 2
- 2007: 2
- 2005: 2
- 2004: 1
Awards (most recent first)
A sensitive and specific serology test for evaluating potency of whole cell Pertussis vaccines
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2025 · $300,000
Aug 25, 2025 – Jul 31, 2027
- Active
Solicitation PA24-245 (2024) · Topic NIAID
Optimizing immunogenicity of novel Cryptosporidium vaccine candidates
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2025 · $300,000
Aug 12, 2025 – Jul 31, 2027
- Active
Solicitation PA24-245 (2024) · Topic NIAID
SBIR Topic 133: Development of a Serological Test for Herpes Simplex Types 1 and 2 Infections
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2024 · $300,000
Solicitation PHS-2024-1 (2024) · Topic 133
Identification of Serodiagnostic Epitopes for SARS-CoV-2, endemic HCoV?s and influenza virus
SBIR Phase I · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2021 · $243,000
Sep 30, 2021 – Sep 29, 2022
Solicitation PA20-260 (2020) · Topic NCIRD
Identification of bactericidal antibody specificities for the development of novel broad-coverage vaccine candidates against Neisseria meningitidis
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2021 · $596,034
May 12, 2021 – Apr 30, 2023
Solicitation PA20-260 (2020) · Topic NIAID
Scanning the Cryptosporidium proteome for vaccine antigens
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $599,999
Apr 1, 2020 – Mar 31, 2022
Solicitation PA19-272 (2019) · Topic NIAID
Discovery of Treponema pallidum antigens for development of a sensitive and specific diagnostic test for syphilis
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2020 · $600,000
Jan 1, 2020 – Dec 31, 2021
Solicitation PA18-574 (2018) · Topic NIAID
Pan-HIV Incidence Assay Development
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $225,707
Aug 16, 2018 – Jul 31, 2019
Solicitation PA16-302 (2016) · Topic NIAID
Protective biomarkers for the development of novel serotype-independent protein-based vaccine candidates against pneumococcus
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $224,852
Mar 22, 2018 – Feb 28, 2019
Solicitation PA17-302 (2017) · Topic NIAID
Discovery of Yellow Fever Virus-Specific Epitopes for Development of an Accurate Serodiagnostic Assay
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $595,243
Jan 16, 2018 – Dec 31, 2020
Solicitation PA16-302 (2016) · Topic NIAID
Identification of Brucella canis seroreactive antigens using a pan Brucella proteome microarray
SBIR Phase I · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2018 · $150,000
Solicitation year 2018 · Topic ODCDC
Specific Detection of Antibodies to Emerging and Established Arboviruses Including Zika Virus
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2017 · $224,958
Feb 6, 2017 – Jan 31, 2019
Solicitation PA16-302 (2016) · Topic NIAID
A NOVEL IMMUNO-PROTEOMIC APPROACH TO A GENITAL HERPES VACCINE
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $224,911
Aug 1, 2016 – Jul 31, 2018
Solicitation PA15-269 (2015) · Topic R
Point of Care Detection of Oral Pathogens
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $225,000
Aug 20, 2015 – Aug 19, 2016
Solicitation DE15-002 (2015) · Topic NIDCR
Development of a Pan-HIV Proteomic Chip
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2014 · $225,000
Solicitation PA13-088 (2014) · Topic NIDCR · Research partner: Stub
Integrated Microfluidic Platform for Point-of-Care Serodiagnostics
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2012 · $600,000
Solicitation PA10-123 (2012) · Topic NIAID · Research partner: Stub
Protective biomarkers for the development of vaccines against malaria
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2012 · $2,341,413
Solicitation PA10-123 (2012) · Topic NIAID · Research partner: Stub
Scanning Chlamydia proteome for vaccine antigens
STTR Phase II · Department of Health and Human Services (National Institutes of Health) · 2009 · $1,847,310
Solicitation PHS2009-2 (2009)
Antibodies to malaria blood stages in mixed-species infections
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2008 · $594,009
Solicitation PHS2007-2 (2008)
Seriodiagnostic arrays for biodefense and emerging infectious diseases
SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2008 · $2,991,860
Solicitation PHS2007-2 (2008)
Scanning Chlamydia proteome for vaccine antigens
STTR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $300,000
Solicitation year 2007 · Research partner: UNIVERSITY OF CALIFORNIA, IRVI
Development of a multiplex serodiagnostic assay for B burgdorferi infection
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2007 · $525,836
Solicitation year 2007
Adjuvants for Agile Vaccine Development
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $886,845
Solicitation PHS2005-2 (2005)
Scanning the P. falciparum proteome for vaccine antigens
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2005 · $598,668
Solicitation PHS2005-2 (2005)
Vaccinia Proteome Affinity Reagents From Phage Display
SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2004 · $995,030
Solicitation PHS2004-2 (2004)
Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026
FedRAMP offerings
No FedRAMP Marketplace listing
Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded
Exclusions & screening
SAM.gov exclusions
Not yet checked against SAM.gov exclusions.
Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.
Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded
Consolidated Screening List
No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).
The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.
Source: ITA Consolidated Screening List (opens in a new tab) · as of Nov 13, 2026
GSA CALC+ rate benchmark
No GSA CALC+ rates on record
Source: GSA CALC+ awarded ceiling rates (opens in a new tab) · sync date not recorded
NAICS, PSC & socio-economic status
NAICS codes
- 541714Research and Development in Biotechnology (except Nanobiotechnology)PrimarySmall business under this code’s size standard
SAM.gov reports this entity as small under 1 of 1 NAICS code. Size is determined per code (SBA size standards).
Product & service codes (PSC)
- AJ11GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
- AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.
Teaming preferences
This company has not published teaming preferences.
Business development contact
No BD contact published
Corporate hierarchy
No parent entity reported in SAM.gov.
SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.
Data sources & provenance
SAM.gov
Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.
USAspending.gov
Prime award history and obligations (FPDS), synced nightly.
The contractor
Nothing yet: this profile has not been claimed by the company.
TeamingIndex verification
Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.
Corrections
Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)
Machine-readable: capability.md schema.org JSON-LD embedded in this page.
Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.
Teaming
Ready to team with IMMPORT THERAPEUTICS INC?
Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.